Search

everythinglearnresearchcommunity

for

Search:↓

Two new reliable Arabic questionnaires for measuring quality of life in women with PCOS were created, one for married and one for unmarried women.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Exosomes from stem cells help hair regrowth by activating a specific signaling pathway.

Testosterone raises blood pressure by affecting kidney function and brain gene regulation over time.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

The secretome from mesenchymal stromal cells shows promise for improving facial nerve injury treatment.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

Blocking the FGF5 gene in sheep leads to more fine wool and active hair follicles due to changes in certain cell signaling pathways.

TrichoScan helps identify subtle hair thinning in women with androgenetic alopecia.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Testosterone raises blood pressure and changes kidney protein levels.

Estrogen and prolactin may play bigger roles in female hair loss than previously thought.

Testosterone changes important cell communication proteins in pregnant rats' uteruses, which might affect pregnancy success.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.

Male yak hair growth is influenced by DHT synthesis, which is promoted by 5α-red1 and AR during growth phases, while E2 may inhibit growth through ERα.

Women with PCOS have higher hair cortisol levels, which are linked to worse metabolic and inflammatory conditions.

Dianabol boosts muscle growth but has serious health risks and legal issues.

Reduced AR gene methylation may cause early pubic hair growth in girls.

Mutations in certain receptors can cause diseases and offer new treatment options.

RE-ORGA, a Korean herb extract, may help prevent hair loss.

High androgen levels in young women with PCOS are linked to higher blood pressure.

New hair loss treatments could be improved by using combined biological markers.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

The document concludes that hair biology is complex and there are still unanswered questions about hair loss and follicle changes.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.